• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Moderna Inc (NQ: MRNA )

    133.27 -4.63 (-3.36%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Jun 18, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 3,970,231
    Open 136.58
    Bid (Size) 132.85 (3)
    Ask (Size) 133.20 (3)
    Prev. Close 137.90
    Today's Range 131.52 - 137.27
    52wk Range 62.55 - 170.47
    Shares Outstanding 383,000,000
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    S&P 500, Nasdaq Lurking Below Record Highs
    Stocks are scattered this afternoon, as investors digest a weaker-than-expected retail sales reading from May. 
    Via Talk Markets
    Topics Stocks
    Exposures US Equities
    Covid-19 Pharma Stars Continue Their Quest To Set New Standards In Cancer Treatment
    AstraZeneca PLC (NASDAQ: AZN) kicked off the week by receiving approval from the U.S. Food and Drug Administration for its blockbuster cancer drug Imfinzi combined with chemotherapy being used as a... 
    Via Benzinga
    Exposures COVID-19

    Performance

    YTD
    +18.46%
    +18.46%
    1 Month
    -5.49%
    -5.49%
    3 Month
    +26.79%
    +26.79%
    6 Month
    +49.59%
    +49.59%
    1 Year
    +7.28%
    +7.28%

    More News

    Read More
    The RBA Kept Interest Rates On Hold And Remained Hawkish
    Via Talk Markets
    OpenAI And Color Health Develop AI-Driven Cancer Care Solutions: Report
    Via Benzinga
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    Moderna Stock Soars on Cutting-Edge Personalized Cancer Vaccines
    Via MarketBeat
    Exposures COVID-19
    Smart Money Is Betting Big In MRNA Options
    Via Benzinga
    Moderna Files FDA Application for the JN.1 Targeting COVID-19 Vaccine
    Via ACCESSWIRE
    Moderna Just Gave Investors Another Reason to Buy the Stock
    Via The Motley Fool
    Moderna Announces Positive Phase 3 Efficacy Data for mRNA-1283, the Company’s Next Generation COVID-19 Vaccine
    Via ACCESSWIRE
    7 Struggling Stocks to Sell Before July 2024
    Via InvestorPlace
    3 Vaccine Stocks to Buy as the FDA Cracks Down on New Variants
    Via InvestorPlace
    Exposures Product Safety
    Moderna, Inc. (MRNA) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
    From Bronstein, Gewirtz & Grossman, LLC
    Via Business Wire
    What's Going On With Moderna Stock Monday?
    Via Benzinga
    Exposures COVID-19
    Nike, Merck, General Motors, And More: CNBC's 'Final Trades'
    Via Benzinga
    Moderna Says Combination Flu And Covid Vaccine Beat Out Rivals From Sanofi, GSK
    Via Investor's Business Daily
    Exposures COVID-19
    Why Moderna Stock Is a No-Brainer Buy Right Now
    Via The Motley Fool
    Moderna Announces Positive Phase 3 Data for Combination Vaccine Against Influenza and COVID-19
    Via ACCESSWIRE
    3 Reasons to Buy Moderna Stock
    Via The Motley Fool
    Moderna Seeks FDA Approval For Updated COVID-19 Shot For Upcoming Season
    Via Benzinga
    Exposures COVID-19 Product Safety
    5 Stocks Propelling S&P 500 To 25th Record High
    Via Talk Markets
    Topics Stocks
    Exposures US Equities
    Meme Stocks Surge Led by ‘Roaring Kitty’ and Social Media Buzz on Reddit (NYSE: RDDT), GME, DYAI, AMC, PRSO, NVAX
    Via AB Newswire
    First Human Death From Bird Flu Strain Puts Vaccine Stocks Back On The Map
    Via Benzinga
    Novavax Stock’s Recent Surge and Future Potential
    Via MarketBeat
    Topics Economy
    Exposures COVID-19 Product Safety Supply Chain
    FDA Selects Moderna's Rare Disease Candidate For Accelerated Development Program
    Via Benzinga
    Exposures Product Safety
    Is a Giant Short Squeeze Brewing in Novavax (NVAX) Stock?
    Via InvestorPlace
    Exposures COVID-19
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.